# PDUFA development checkpoint — October 27, 2026 Pacific

Repository: `pdufa/pdufa-command-center`. Development branch: `feature/decision-workstream-20261026`. Existing draft PR: #498. Never merge it or push to main, deploy to production, change live scan schedules, place real/paper trades, or alter GEM JR/GEM/WT restrictions or separate FS/FA associations without explicit authorization.

## Latest first-trial priority continuation — read first

Latest report: `docs/decision-first-trial-progress-20261027.md`. The user now
prioritizes one real current trial over completing the whole historical database.
COGT PEAK (NCT05208047, CGT9486-21-301) has a saved, source-cited assessment and
actual dashboard display at `/prediction-pilot`: **INCOMPLETE / INDETERMINATE**,
9 findings, 3 selected historical contexts, **0/40 SCIENCE assessments**, no
probability/confidence, no trading authorization. One saved research abstention
is not a completed scientific workflow; **0 full cases completed, 0 queued**.
Do not activate batch processing until the first case passes all required checks.

Reviewed SCIENCE criteria, original PEAK protocol/SAP, exact current application
and persistent registry reconciliation, historical-cycle adjudication and a
justified preliminary classification method remain missing. Do not invent them.
Full/stage processing time is unmeasured; the saved 1.633 ms evaluator runtime
excludes research and cannot establish the 45-minute objective.

Recovered and pinned three existing Actions metadata artifacts under
`research/fda/recovered-20261027/`; source-only importer created the ignored
research database `work/phase2-20261027/historical-source-metadata.sqlite3`.
458 letters, 29,416 registry applications, 188,890 submission observations;
independently adjudicated eligible PASS/FAIL/backtest cases **0/0/0**.
Original FDA document/manifest/archive bytes remain absent. Optional future
original-byte retention was implemented but not enabled in any live workflow.

Preserved all **84** upstream commits through `2ffbfba0` via same-branch merge
`bc8aefdc`. Both earlier requested commits remain ancestors. Post-integration
verification: **2,611 Python passed, 1 existing skip, 557 subtests; 665 frontend
passed; TypeScript/build passed**. All **15 GitHub workflows passed at
`66087103`**, which was pushed normally to the development branch and PR #498.
Vercel marked its branch preview Ready, but actual preview fetch returned
permission **403** at deployment alias access; rendered remote content remains
unverified. Authorize team `pdufa` / project `pdufa-new-dashboard` in the connection
and confirm account access before retrying. No CLI fallback is installed;
no protection or production changes are authorized. No operational scan timing
or restriction/FS/FA association was edited.

## Earlier master-directive continuation

The PR advanced by 49 commits after this checkpoint, through `8a0f1184`.
All were fast-forwarded and preserved before continuing. Both `dd4f9f65` and
`e5800a07` remain in history. The governing document is now
`docs/MASTER_PDUFA_PASS_FAIL_DIRECTIVE.md`. The sections below retain the earlier
session's verified results and are not the latest full-suite counts.

Latest continuation report:
`docs/decision-master-directive-progress-20261027.md`. Implementation commits:
`e59f3a2a`, `43defa46`, `a58f3f4c`, `c74939ae`, `cf93ffc3`, `6b109651`.
They add retained-byte FDA intake, separate JSON feature/outcome chronology,
honest candidate-only cycle matching/staging, rescission/correction dependency
review, qualitative SCIENCE direction and adversarial arguments, and explicit
INSUFFICIENT EVIDENCE prediction abstention. Original receipt timestamps follow
document acquisition and hashing. No trained/validated prediction is installed.

Three real FDA PDF text observations for ZEVASKYN are committed under
`research/fda/`. They show one CRL and a later approval, plus FDA resubmission
history. Original PDF bytes and publication/cycle adjudication remain unavailable;
verified eligible PASS = 0, FAIL = 0, model-eligible = 0 for this intake. Direct
acquisition returned `Tunnel connection failed: 403 Forbidden` without creating
an archive. Use supported network configuration or reviewed offline originals;
never promote connected-tool transcriptions into original PDFs or predecision
features. Next task is independent document/cycle/coverage adjudication and real
point-in-time evidence, followed by the existing blinded validation gates.

No production database, schedule/configuration, restriction/FS/FA association or
trading permission was modified. All work stays on the named feature branch and
existing draft PR #498.

## Starting state and preserved work

The pasted request identified remote head `b80577c449b4ba123b64cee9bac24d520b2e2194`. Local uncommitted work was checkpointed before fast-forwarding to that head; the five intervening remote commits, frozen market-cap file and supported SCANS regression were preserved. All eight GitHub workflows on that starting head were successful. The older PR description's census CI failure was already resolved by those remote corrections.

An earlier local stash named `PDUFA checkpoint before incorporating b80577c4` remains for recovery. It contains superseded intermediate census/schedule/test work; **do not apply it wholesale over the verified branch**. The reconciliation patch/status are under ignored `work/resume-20261027/`. All useful subsequent work has been reconciled into the commits below.

## Completed implementation

- `738f610f`: retain the approved immutable market-cap file and freeze the other three census inputs at their actual `b80577c4` bytes. Pin all hashes in the builder/parser, preserve Git/SHA-256 provenance and CRLF byte identity, reject changed/missing snapshots and forbid live-source fallback. No original observation timestamp or cutoff changed.
- `9b01a38d`: test the dated public census against its frozen source inventory, rather than mutable current scanner data. All 741 trial / 130 company mappings and original research-only gates are retained.
- `b760e7d1`: authenticated read-only reviewed-manifest endpoint, strict bounded identity/schema validation and opt-in stable-file loader; scientific dossiers with 20 levels / 40 assessments / eight layers; citations, critical evaluation, uncertainty, current-readiness and reluctant-assessment grades. Connect these to the existing dashboard/composer, require declared OUTCOME application and MAIN company identity agreement, and keep incomplete/stale/conflicting data blocked.
- `db8196c3`: migrate 20 retired-app test modules to actual Next.js/FastAPI contracts without skips or app restoration; retain historical/FDA/data/security checks; make the smoke module import-safe. Fix the genuine index-aligned Pipeline mask defect. Isolate the four-button filings authorization fixture from unrelated bulk source reconciliation. Add complete maintained-suite CI and a read-only clock audit.

## Verification on the completed code

| Check | Result |
| --- | --- |
| All frontend files (`npm test`) | 90 passed |
| Direct per-file frontend execution | 619 individual tests passed |
| TypeScript (no incremental cache) | Passed |
| Isolated local Next.js build | Passed; no release/deployment |
| Complete default pytest discovery and execution | 2,194 passed, 1 skipped, 550 subtests passed |
| Frozen census Python regressions | 4 passed, 4 subtests passed |
| Census source/rows/evidence-gap frontend regressions | Passed |
| Schedule regression subset | 12 passed, 2 subtests passed |
| Source/whitespace checks | Passed; immutable CRLF inputs explicitly retain their original bytes |

The default Python run includes backend, retained legacy engines, root OUTCOME and import-safe smoke coverage. Its 13 warnings are existing dependency/Pandas deprecations. One remaining backend opt-in smoke test is skipped as before. An initially exposed AppTest timeout was fixed at the fixture's complete data-loader boundary; the timeout was not increased and no test was skipped. The new read-only CI workflow installs both supported runtimes and executes default pytest so these tests cannot silently drop from future checks.

Local logs: `work/resume-20261027/{final-python-all.log,final-frontend-direct.log,final-frontend-summary.json,final-frontend-npm.log,final-build.log,schedule-audit.json}`. Additional migration diagnostics are under `work/test-migration/`. These ignored files are execution artifacts, not source evidence. Check the latest PR-head Actions results after pushing; earlier CI success is not a substitute for verification of the new head.

## Scientific and system readiness

| System | Implemented and tested | Remaining evidence |
| --- | --- | --- |
| SCIENCE | Full inventory contract, original citation chronology, completeness counts, critical evaluation, uncertainty, cautious grades and trial dossier display | Actual independently reviewed 20-level / 40-assessment / eight-layer dossiers and their original protocol/source records |
| Historical FDA / OUTCOME | Existing evidence ledger, outcome/source chronology, frozen holdout diagnostics and application partition isolation; reviewed identity transport | Complete approval/nonapproval denominator, original FDA action/indication/cycle records, genuine frozen forecasts, independent holdout/forward validation |
| MAIN | Existing market/research boundaries preserved; declared company CIK bound to scientific identity, original financial/source tests retained | Audited exact-program market captures, company/application crosswalk and independent financing/runway/ownership/risk source review |
| DECISION | Authenticated evidence connection, exact trial/stage isolation, five prerequisite groups, current readiness and separate system progress | Complete independently verified inputs and validated prospective evidence; no operational recommendation/trading authorization |

No real scientific dossier, FDA outcome or predecision forecast was manufactured. Synthetic fixtures remain test-only. Valid schema, matching identifiers, reviewer flags, URLs and SHA-256 digests do not independently verify original source truth. Product outputs remain `modelValidated: false`, `probability: null`, `tradeAuthorized: false`. Missing source populations are not reported as zero-percent completion. No defensible delivery ETA or validated prediction accuracy is available.

## Schedule investigation

The approved executable launcher and DST admission script use **20:00 America/Los_Angeles**. Saved preflight metadata still says **22:00** and has older cron labels; it is not the runtime clock authority. The read-only audit exposes `METADATA_DRIFT` separately from `runtime_status: CONSISTENT`, returns exit 2 for that maintenance warning, records input hashes, and dispatches nothing. The PR CI emits the warning but fails an actual runtime conflict. Live launcher/admission files and saved configuration were not changed. README's active-clock documentation now describes the existing 8 PM behavior; historical notes are explicitly distinguished.

Read-only inspection of published main snapshot `2d3b350` and run 40443182030 confirmed successful collector, report, source-review, scoring/error-audit, final-result and archive steps. Its saved published report remains `PARTIAL`, with six missing verification families; collector completion does not establish full evidence completeness. A direct workflow-state CLI lookup was denied by network policy, so no independent enable/disable-state claim is made from that request.

## Next tasks and blocking inputs

1. Inspect CI on the newly pushed PR #498 head, including the new full Python/support-contract workflow. Correct confirmed software/fixture defects without weakening source gates.
2. Supply original independently reviewed dossiers/identity mappings and point-in-time FDA/forecast/market evidence. The source endpoint requires an explicitly configured `PDUFA_DECISION_EVIDENCE_DIR`; it is unconfigured by this development work and no default evidence is loaded. See `decision-reviewed-evidence-transport.md` and `decision-scientific-dossiers.md`.
3. Official FDA host access remains outside this execution environment's enforced allowlist. Obtain supported network configuration approval or reviewed offline exports; never bypass policy or generate missing historical forecasts after observing outcomes.
4. Review stale saved clock metadata separately if its descriptive labels should be aligned. No operational scan timing change is necessary to retain the approved 8 PM clock.
5. The retained filings renderer performs repeated bulk Pipeline/SEC reconciliation; the isolated control fixture no longer triggers that unrelated workload. A separately benchmarked performance improvement is possible if that retained renderer is maintained further, with no change to its results or authorization boundary.

The working branch continues the user's existing work; production, live source datasets, restrictions, FS/FA associations and trading permissions remain untouched. Push only this feature branch and update the existing draft PR; existing Vercel automation may create a branch preview, but no production release is authorized.
